COVID-19 and Sepsis: Discussing the Guidelines with People Who Wrote Them
Recorded On: 09/17/2020
It is important to know and to utilize the Surviving Sepsis Campaign (SSC) Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) as well as The National Institutes of Health (NIH) COVID-19 Treatment Guidelines. Case studies will incorporate the guidelines as used in clinical practice. Topics of discussion, as they relate to the latest guidelines, will include: hemodynamic, ventilatory support, and drug therapy.
At the end of the activity, the learner should be able to:
- Review the recommendation ratings related to strength and quality of evidence supporting their various recommendations;
- Identify the guidelines for management and treatment of COVID-19 patients to optimize patient care;
- Describe the patient case scenarios and the relevant guidelines used in clinical practice.
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Steven Q. Simpson, MD
Professor of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine
University of Kansas
Steven Q. Simpson, MD is Professor of Medicine at the University of Kansas in the Division of Pulmonary, Critical Care, and Sleep Medicine, where he previously served as Division Director, Director of three ICUs, Chair of the Sepsis Team, and Chair of Multidisciplinary Critical Care. He has done research in all areas of severe sepsis from molecular and cellular mechanisms, to translational studies, to quality improvement studies.
He was a founder, in 2005, of the Midwest Critical Care Collaborative, a multidisciplinary and interprofessional collaborative effort to improve the quality of critical care services throughout the Midwest. In 2007, he initiated the Kansas Sepsis Project, a statewide program to improve severe sepsis care and outcomes throughout the state via continuing education both in sepsis and in quality improvement principles, and via inter-professional collaboration. He is currently heading a BCBS-sponsored sepsis collaborative among Kansas City metro area hospitals and is a contributing faculty member of the ongoing Surviving Sepsis Campaign collaboratives, leading the effort in the Midwest. He is a participant in the 2016 review and update of the Surviving Sepsis Campaign Guidelines.
Dr. Simpson was the North American co-chair of the International Single Day Point Prevalence Study for Severe Sepsis and Septic Shock (IMPRESS) in the fall of 2013. During his tenure at the University of New Mexico, he contributed to the discovery of a particular form of sepsis, the Hantavirus Pulmonary Syndrome, and published numerous papers on the clinical description, the hemodynamic description, and the approach to supportive care for patients with the syndrome, including extracorporeal hemodynamic and oxygenation support.
Dr. Simpson received his M.D. degree from the University of Kansas in 1983. He completed residency training in Internal Medicine at KU in 1986 and fellowship training in Pulmonary Diseases at Rush Medical College in 1989. He has been a faculty member at Rush Medical College, the University of New Mexico, and the University of Kansas. He is a regular reviewer for the journals Critical Care Medicine and CHEST, and he reviews on an ad hoc basis for Shock, the Journal of Intensive Care, JAMA, Virology, and Antiviral Therapy. He is the author of over 70 peer reviewed and invited manuscripts, book chapters, and web-based articles and presentations.
Dr. Simpson was the Third Eli Lilly and Company Distinguished Scholar in Critical Care Medicine, sponsored by the American College of Chest Physicians and the Chest Foundation for his work in reducing geographic disparities for severe sepsis care (the Kansas Sepsis Project). In 2013 he delivered the Roger C. Bone Memorial Lecture at the annual international meeting of the American College of Chest Physicians, describing the Kansas Sepsis Project. Dr. Bone was Dr. Simpson’s early career mentor and was the progenitor of the criteria used throughout the world to recognize severe sepsis.
No relevant financial relationships to disclose.
Laura Evans, MD, MSc
Professor, Division of Pulmonary, Critical Care, and Sleep Medicine; Medical Director, Critical Care
University of Washington Medical Center
Dr. Evans is a Professor of Medicine at the University of Washington and the Medical Director of Critical Care at the University of Washington Medical Center. Her interests focus on patient safety and quality improvement, particularly sepsis, as well as preparedness for high consequence infectious diseases. Dr. Evans earned her MD at the University of Michigan and did her residency in internal medicine at Columbia University. She completed pulmonary and critical care medicine fellowship training and earned an MS in epidemiology at the U. of Washington. She joined the faculty of NYU and Bellevue Hospital in 2006. She led the evacuation of the Bellevue Hospital ICUs in the aftermath of Hurricane Sandy and was the clinical lead for New York City’s Ebola treatment center. After 14 years in NYC, she returned to Seattle in 2019. She joined the steering committee of the Surviving Sepsis Campaign in 2012 and is the current Surviving Sepsis Campaign guidelines co-chair. She serves on the Council of the Society of Critical Care Medicine. She is Associate Editor of Critical Care Explorations and a member of the editorial board of Critical Care Medicine.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.7 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.25 contact hours.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.